Shu Hashimoto

6.4k total citations · 1 hit paper
169 papers, 5.0k citations indexed

About

Shu Hashimoto is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Shu Hashimoto has authored 169 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 55 papers in Physiology and 44 papers in Molecular Biology. Recurrent topics in Shu Hashimoto's work include Asthma and respiratory diseases (43 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers). Shu Hashimoto is often cited by papers focused on Asthma and respiratory diseases (43 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers). Shu Hashimoto collaborates with scholars based in Japan, United States and Denmark. Shu Hashimoto's co-authors include Takashi Horie, Yasuhiro Gon, Ken Matsumoto, Ikuko Takeshita, Shuichiro Maruoka, Yoshiaki Abe, Kenji Mizumura, Tomoko Nakayama, Augustine M.K. Choi and Kazufumi Shimizu and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Shu Hashimoto

160 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD

2014 481 citations Kenji Mizumura, Suzanne M. Cloonan et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu Hashimoto Japan	40	1.7k	1.5k	1.2k	1.2k	685	169	5.0k
Matthew E. Poynter United States	42	1.9k 1.1×	1.4k 0.9×	2.0k 1.6×	2.0k 1.7×	627 0.9×	145	6.1k
Fuqiang Wen China	40	2.1k 1.3×	2.9k 1.9×	1.0k 0.8×	1.2k 1.1×	668 1.0×	341	6.7k
Vincent Lagente France	44	2.3k 1.4×	2.3k 1.5×	1.5k 1.2×	1.9k 1.6×	584 0.9×	187	7.1k
Brent W. Winston Canada	34	1.8k 1.0×	696 0.5×	806 0.7×	394 0.3×	1.4k 2.0×	79	5.5k
Michael T. Borchers United States	36	977 0.6×	909 0.6×	1.1k 0.9×	1.4k 1.2×	277 0.4×	87	4.1k
Charles C. Caldwell United States	43	2.2k 1.3×	685 0.5×	2.3k 1.9×	568 0.5×	1.3k 2.0×	157	6.7k
Igor Theurl Austria	49	1.4k 0.8×	487 0.3×	1.7k 1.4×	730 0.6×	1.1k 1.6×	119	8.1k
Feng Xu China	35	2.2k 1.3×	912 0.6×	643 0.5×	394 0.3×	400 0.6×	129	4.5k
Takahide Nagase Japan	41	2.8k 1.7×	2.4k 1.6×	1.2k 1.0×	1.8k 1.5×	652 1.0×	288	7.7k
Urszula Demkow Poland	34	1.0k 0.6×	735 0.5×	1.4k 1.2×	794 0.7×	795 1.2×	305	4.6k

Countries citing papers authored by Shu Hashimoto

Since Specialization

Citations

This map shows the geographic impact of Shu Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Hashimoto more than expected).

Fields of papers citing papers by Shu Hashimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Hashimoto. The network helps show where Shu Hashimoto may publish in the future.

Co-authorship network of co-authors of Shu Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Hashimoto. A scholar is included among the top collaborators of Shu Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Hashimoto. Shu Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hashimoto, Shu, et al.. (2023). Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study. International Journal of COPD. Volume 18. 37–46. 9 indexed citations

Takeuchi, Suguru, Masaaki Takamura, Tomoaki Yoshida, et al.. (2018). Ombitasvir–Paritaprevir–Ritonavir Therapy in a Kidney Transplant Recipient With Chronic Hepatitis C Virus Genotype 1 Infection: A Case Report on the Importance of Considering Drug–Drug Interactions and Monitoring Cyclosporine Levels. Transplantation Proceedings. 50(3). 884–886. 1 indexed citations

Mizumura, Kenji, Suzanne M. Cloonan, Kiichi Nakahira, et al.. (2014). Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. Journal of Clinical Investigation. 124(9). 3987–4003. 481 indexed citations breakdown →

Takahashi, Noriaki, Yoshihiro Sato, Tetsuo Shimizu, & Shu Hashimoto. (2014). End of life care for lung cancer patients. 24(2). 175–178. 1 indexed citations

Ito, Reiko, Yasuhiro Gon, Satoshi Nunomura, et al.. (2014). Development of Assay for Determining Free IgE Levels in Serum from Patients Treated with Omalizumab. Allergology International. 63. 37–47. 13 indexed citations

Maruoka, Shuichiro, Yasuhiro Gon, Daisuke Koyama, et al.. (2014). Exosomal microRNAs in the serum are potential real-time biomarkers for allergic inflammation in the airway of mice. European Respiratory Journal. 44(Suppl 58). P1010–P1010. 1 indexed citations

Fujii, Toshio, et al.. (2009). [Case of drug-induced pneumonia due to Saiko-karyuukotsu-boreitou].. PubMed. 47(5). 362–6. 2 indexed citations

Hashimoto, Shu, et al.. (2008). A case of foreign body (crab's leg) aspiration in the left main bronchus which required removal under right thoracotomy. The Journal of the Japanese Association for Chest Surgery. 22(4). 661–665. 1 indexed citations

Kimura, Hiroshi, Hirohisa Toga, Hiroshi Inoue, et al.. (2006). [A questionnaire report concerning the actual situation of respiratory physicians in Japan].. PubMed. 44(4). 312–8. 2 indexed citations

10.

Hashimoto, Shu, et al.. (2003). A stand-alone wind turbine generator system for a small-scale radio base station. International Telecommunications Energy Conference. 404–409. 11 indexed citations

11.

Hashimoto, Shu, et al.. (2003). Experimental study for wind power - hydrogen energy system with energy capacitor system. International Telecommunications Energy Conference. 451–456. 5 indexed citations

12.

Jibiki, Itsuro, Shu Hashimoto, Shuichiro Maruoka, et al.. (2003). Apoptosis Signal-Regulating Kinase 1–Mediated Signaling Pathway Regulates Nitric Oxide–Induced Activator Protein-1 Activation in Human Bronchial Epithelial Cells. American Journal of Respiratory and Critical Care Medicine. 167(6). 856–861. 37 indexed citations

13.

Hashimoto, Shu & Tomoko Kobayashi. (2002). Current status of idiopathic interstitial pneumonia. 50(9). 869–879. 1 indexed citations

14.

Tsuchiyama, Junjiro, Kento Imajo, T. Yoshino, et al.. (2002). High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases. Annals of Hematology. 81(10). 588–592. 9 indexed citations

15.

Hashimoto, Shu, Yasuhiro Gon, Ikuko Takeshita, et al.. (2001). Transforming Growth Factor- β1 Induces Phenotypic Modulation of Human Lung Fibroblasts to Myofibroblast Through a c-Jun-NH2-Terminal Kinase-Dependent Pathway. American Journal of Respiratory and Critical Care Medicine. 163(1). 152–157. 193 indexed citations

16.

Maruoka, Shuichiro, Shu Hashimoto, Yasuhiro Gon, Ikuko Takeshita, & Takashi Horie. (2000). PAF-induced RANTES Production by Human Airway Smooth Muscle Cells Requires Both p38 MAP Kinase and Erk. American Journal of Respiratory and Critical Care Medicine. 161(3). 922–929. 52 indexed citations

17.

Hashimoto, Shu, Yasuhiro Gon, Ken Matsumoto, et al.. (2000). Inhalant Corticosteroids Inhibit Hyperosmolarity-induced, and Cooling and Rewarming–induced Interleukin-8 and RANTES Production by Human Bronchial Epithelial Cells. American Journal of Respiratory and Critical Care Medicine. 162(3). 1075–1080. 41 indexed citations

18.

Hashimoto, Shu, Yasuhiro Gon, Ikuko Takeshita, et al.. (2000). Diesel Exhaust Particles Activate p38 MAP Kinase to Produce Interleukin 8 and RANTES by Human Bronchial Epithelial Cells and N -Acetylcysteine Attenuates p38 MAP Kinase Activation. American Journal of Respiratory and Critical Care Medicine. 161(1). 280–285. 116 indexed citations

19.

Hashimoto, Shu, et al.. (2000). p38 Mitogen-Activated Protein Kinase and c-Jun-NH2-Terminal Kinase Regulate RANTES Production by Influenza Virus-Infected Human Bronchial Epithelial Cells. The Journal of Immunology. 164(6). 3222–3228. 162 indexed citations

20.

Hashimoto, Shu, Ken Matsumoto, Yasuhiro Gon, et al.. (1999). Hyperosmolarity-induced Interleukin-8 Expression in Human Bronchial Epithelial Cells through p38 Mitogen-activated Protein Kinase. American Journal of Respiratory and Critical Care Medicine. 159(2). 634–640. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact